Microvessel permeability correlates with diabetic peripheral neuropathy in early stage of streptozotocin-induced diabetes rats

Journal of Diabetes and its Complications

Volumn 29, Issue 7, 2015, Pages 865-871

  Peng, Liyuan ^a   Liu, Wei ^a   Zhai, Fanglong ^a   He, Li ^a   Wang, Hailan ^a  

^a ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; Microvessel permeability; nerve conductive velocity; Peripheral neuropathy; VEGF

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DIABETIC NEUROPATHY; GLUCOSE BLOOD LEVEL; MALE; MICROVASCULATURE; MYELIN SHEATH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SCHWANN CELL; SCIATIC NERVE; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WATER CONTENT; ANIMAL; CAPILLARY PERMEABILITY; COMPLICATION; DISEASE MODEL; ELECTRON MICROSCOPY; EXPERIMENTAL DIABETES MELLITUS; IMMUNOHISTOCHEMISTRY; METABOLISM; NEEDLE BIOPSY; NERVE CONDUCTION; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; REFERENCE VALUE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SPRAGUE DAWLEY RAT; TIME FACTOR; ULTRASTRUCTURE; VASCULARIZATION;

ANIMALS; BIOPSY, NEEDLE; CAPILLARY PERMEABILITY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; MICROVESSELS; NEURAL CONDUCTION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; RISK FACTORS; SCIATIC NERVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84939573643     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2015.05.025     Document Type: Article

References (27)

1. Y. Aizu, K. Oyanagi, J. Hu, and H. Nakagawa Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats Neuropathology 22 2002 161 170
2. A.J. Boulton, A.I. Vinik, J.C. Arezzo, V. Bril, E.L. Feldman, R. Freeman, and et al. Diabetic neuropathies: a statement by the American Diabetes Association Diabetes Care 28 2005 956 962
3. M.W. Bradbury, S.L. Lightman, L. Yuen, and G.G. Pinter Permeability of blood-brain and blood-nerve barriers in experimental diabetes mellitus in the anaesthetized rat Experimental Physiology 76 1991 887 898
4. A.E. Caballero, S. Arora, R. Saouaf, S.C. Lim, P. Smakowski, J.Y. Park, and et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes Diabetes 48 1999 1856 1862
5. A.S. de Vriese, R.G. Tilton, M. Elger, C.C. Stephan, W. Kriz, and N.H. Lameire Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes Journal of the American Society of Nephrology 12 2001 993 1000
6. T. Deguchi, T. Hashiguchi, S. Horinouchi, T. Uto, H. Oku, K. Kimura, and et al. Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage Diabetic Medicine 26 2009 247 252
7. P. Fioretto, P.M. Dodson, D. Ziegler, and R.S. Rosenson Residual microvascular risk in diabetes: unmet needs and future directions Nature Reviews Endrocrinology 6 2010 19 25
8. A. Flyvbjerg, F. Dagnaes-Hansen, A.S. De Vriese, B.F. Schrijvers, R.G. Tilton, and R. Rasch Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody Diabetes 51 2002 3090 3094
9. J.W. Han, M.Y. Sin, and Y.S. Yoon Cell therapy for diabetic neuropathy using adult stem or progenitor cells Diabetes & metabolism Journal 37 2013 91 105
10. A. Hosseini, M. Sharifzadeh, S.M. Rezayat, G. Hassanzadeh, S. Hassani, M. Baeeri, and et al. Benefit of magnesium-25 carrying porphyrin-fullerene nanoparticles in experimental diabetic neuropathy International Journal of Nanomedicine 5 2010 517 523
11. S. Ishida, T. Usui, K. Yamashiro, Y. Kaji, E. Ahmed, K.G. Carrasquillo, and et al. VEGF164 is proinflammatory in the diabetic retina Investigative Ophthalmology & Visual Science 44 2003 2155 2162
12. H. Kim, J.J. Kim, and Y.S. Yoon Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves Endocrine, Metabolic & Immune Disorders Drug Targets 12 2012 168 178
13. J. Lincoln, M. Crockett, A.J. Haven, and G. Burnstock Rat bladder in the early stages of streptozotocin-induced diabetes: adrenergic and cholinergic innervation Diabetologia 26 1984 81 87
14. M. Nowicki, J. Kosacka, H. Serke, M. Bluher, and K. Spanel-Borowski Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, peripheral diabetic polyneuropathy, and the metabolic syndrome Journal of Neuroscience Research 90 2012 122 131
15. M. Oubaha, and J.P. Gratton Phosphorylation of endothelial nitric oxide synthase by atypical PKC zeta contributes to angiopoietin-1-dependent inhibition of VEGF-induced endothelial permeability in vitro Blood 114 2009 3343 3351
16. J.F. Poduslo, G.L. Curran, and P.J. Dyck Increase in albumin, IgG, and IgM blood-nerve barrier indices in human diabetic neuropathy Proceedings of the National Academy of Sciences of the United States of America 85 1988 4879 4883
17. E. Rechthand, Q.R. Smith, C.H. Latker, and S.I. Rapoport Altered blood-nerve barrier permeability to small molecules in experimental diabetes mellitus Journal of Neuropathology and Experimental Neurology 46 1987 302 314
18. A. Samii, J. Unger, and W. Lange Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats Neuroscience Letters 262 1999 159 162
19. P. Santicioli, R. Gamse, C.A. Maggi, and A. Meli Cystometric changes in the early phase of streptozotocin-induced diabetes in rats: evidence for sensory changes not correlated to diabetic neuropathy Naunyn-Schmiedeberg's Archives of Pharmacology 335 1987 580 587
20. J.N. Scott, A.W. Clark, and D.W. Zochodne Neurofilament and tubulin gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons Brain 122 Pt 11 1999 2109 2118
21. Y. Shen, A. Zhang, J. Guo, G. Dan, S. Chen, and H. Yu Fluorescence imaging of Evans blue extravasation into mouse brain induced by low frequency ultrasound with microbubble Biomedical Materials and Engineering 24 2014 2831 2838
22. M. Sjoquist, W. Huang, and B.L. Johansson Effects of C-peptide on renal function at the early stage of experimental diabetes Kidney International 54 1998 758 764
23. M. Sondell, F. Sundler, and M. Kanje Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor European Journal of Neuroscience 12 2000 4243 4254
24. S. Tesfaye, A.J. Boulton, P.J. Dyck, R. Freeman, M. Horowitz, P. Kempler, and et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments Diabetes Care 33 2010 2285 2293
25. Y. Wang, D.P. Brown Jr., Y. Duan, W. Kong, B.D. Watson, and J.L. Goldberg A novel rodent model of posterior ischemic optic neuropathy JAMA Ophthalmology 131 2013 194 204
26. Y. Wang, J.D. Schmelzer, A. Schmeichel, H. Iida, and P.A. Low Ischemia-reperfusion injury of peripheral nerve in experimental diabetic neuropathy Journal of Neurological Sciences 227 2004 101 107
27. J. Zenker, D. Ziegler, and R. Chrast Novel pathogenic pathways in diabetic neuropathy Trends in Neurosciences 36 2013 439 449